Recommended standards for modern tuberculosis laboratory services in Europe

被引:33
作者
Drobniewski, F. A.
Hoffner, S.
Rusch-Gerdes, S.
Skenders, G.
Thomsen, V.
机构
[1] Queen Mary Coll, Barts & London Sch Med, Ctr Infect Dis,Head Clin TB & HIV Grp, Inst Cell & Mol Sci,Hlth Protect Agcy Natl Mycoba, London E1 2AT, England
[2] Swedish Inst Infect Dis Control, Stockholm, Sweden
[3] Forschungszentrum Borstel, Borstel, Germany
[4] Natl TB Inst, Riga, Latvia
[5] Statens Serum Inst, Copenhagen, Denmark
关键词
culture; guidelines; microscopy; molecular testing; training; tuberculosis;
D O I
10.1183/09031936.06.00084906
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The principles underpinning these standards are that any tuberculosis laboratory-based diagnostic procedure should be performed by appropriately trained staff, working to standardised operating procedures in appropriately equipped and safe laboratories, against clear national and international proficiency and quality standards. Quality should be the pre-eminent criteria, not cost. The standards are technologically feasible, but initially may not be within the financial capacity of all laboratories. There is a requirement for government and international donors to adequately fund an appropriate safe infrastructure to enable staff to deliver accurate and timely results at whatever level of activity they are performing. There is a need for national reference laboratories to train a new cadre of mycobacterial laboratory experts. This will require the funding of appropriate individuals at these centres to train and assist in the implementation of good laboratory practice and evaluation to build sustainable capacity. Further operational research is needed to establish the optimal configuration of new technologies to determine isoniazid, rifampicin and second-line drug susceptibility in mycobacterial cultures and also, increasingly, directly on specimens. Improved integration of laboratory medicine as a core part of all tuberculosis programmes is needed to achieve and maximise the potential of new developments.
引用
收藏
页码:903 / 909
页数:7
相关论文
共 67 条
[1]  
*ADV COMM DANG PAT, 2001, MAN DES OP MICR CONT
[2]  
Albert H, 2002, INT J TUBERC LUNG D, V6, P523
[3]  
Alcaide F, 2000, J CLIN MICROBIOL, V38, P398
[4]  
[Anonymous], 1972, LANCET, V1, P1079
[5]  
[Anonymous], 1976, Am Rev Respir Dis, V114, P471
[6]  
[Anonymous], GUID PROGR MAN DRUG
[7]  
[Anonymous], 2006, J HOSP INFECT
[8]  
*ASS PUBL HLTH LAB, 2004, FUT TB LAB SERV FRAM
[9]  
Ba F, 1999, INT J TUBERC LUNG D, V3, P1101
[10]   Comparison of the MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria from various clinical specimens [J].
Brunello, F ;
Favari, F ;
Fontana, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :1206-1209